Prevalence of human papillomavirus types in women screened by cytology in Germany

Journal of Medical Virology

Volumn 79, Issue 5, 2007, Pages 616-625

  Klug, Stefanie J ^a   Hukelmann, Meike ^a   Hollwitz, Bettina ^b   Düzenli, Nurgül ^c   Schopp, Betti ^c   Petry, Karl Ulrich ^d   Iftner, Thomas ^c,e  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Teaching Hospital Wolfsburg   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; HPV prevalence; Screening

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; FEMALE; GENOTYPE; GERMANY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADULT; CARCINOMA IN SITU; COHORT STUDIES; CYTODIAGNOSIS; FEMALE; GERMANY; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; SPECIES SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 34147112821     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20863     Document Type: Article

References (35)

1. Bosch FX, de Sanjose S. 2003. Chapter 1: Human papillomavirus and cervical cancer-Burden and assessment of causality. J Natl Cancer Inst Monogr 31:3-13.
2. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El GF. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol 6:204.
3. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E. 2004. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 57:68-72.
4. de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Munoz N, Catala I, Meijer CJ, Snijders PJ, Herrero R, Bosch FX. 2003. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 30:788-793.
5. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
6. Ferlay J, Bray F, Pisani P, Parkin DM. 2004. GLOBOCAN 2002:Cancer Incidence, Mortality and Prevalence worldwide. IARC CancerBase No 5.
7. Forslund O, Antonsson A, Edlund K, van den Brule AJ, Hansson BG, Meijer CJ, Ryd W, Rylander E, Strand A, Wadell G, Dillner J, Johansson B. 2002. Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women. J Med Virol 66:535-541.
8. Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, Abrahamsen M, Inserra P, Olvera S, Hatch K. 2002. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis 186:462-469.
9. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using Ll consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998. 36:3020-3027.
10. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000. 38:357-361.
11. Herrero R, Munoz N. 1999. Human Papillomavirus and Cancer. Cancer Surv 33:75-98.
12. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. 2005. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191:1796-1807.
13. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. 1995. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87:1365-1371.
14. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423-428.
15. Kahl H, Holling H, Kamtsiuris P. 1999. Utilization of health screening studies and measures for health promotion. Gesundheitswesen 61:S163-S168.
16. Kassenärztliche Bundesvereinigung. 1999. Participation in cancer screening in health insurances since 1972. Basis data for medical care in the Fedseral Republic of Germany 1999.
17. Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, Meijer CL. 2001. High-risk human papillomavirus is sexually transmitted: Evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 10:101-106.
18. Kjaer S, van den Brule AJC, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijer CJLM. 2002. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: Population based prospective follow up study. BMJ 325:572-576.
19. Klug SJ, Hetzer M, Blettner M. 2005. Screening for breast and cervical cancer in a large German city: Participation, motivation and knowledge of risk factors. Eur J Public Health 15:70-77.
20. Lazcano-Ponce E, Herrero R, Munoz N, Cruz A, Shah KV, Alonso P, Hernandez P, Salmeron J, Hernandez M. 2001. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 91:412-420.
21. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A, Munoz N. 2002. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 87:324-333.
22. Moreno V, Bosch FX, Munoz N, Meijer CJLM, Shah K, Walboomers JM, Herrero R, Franceschi S. 2002. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study. Lancet 359:1085-1092.
23. Munoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N. 1992. The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain. Int J Cancer 52:743-749.
24. Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJLM, Bosch FX. 2002. Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet 359:1093-1101.
25. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders P, Meijer CJLM, 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
26. Petry K-U, Menton S, Menton M, van Loenen-Frosch F, de Carvalho Gomes H, Holz B, Schopp B, Garbrecht-Buettner S, Davies P, Boehmer G, van Den Akker E, Iftner T. 2003. Inclusion of HPV-testing in routine cervical cancer screening for women above 29 years in Germany: Results for 8466 patients. Br J Cancer 88:1570-1577.
27. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjose S, Munoz N. 2003. Smoking and cervical cancer: Pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 14:805-814.
28. Schenck U, von Karsa L. 2000. Cervical cancer screening in Germany. Eur J Cancer 36:2221-2226.
29. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85:958-964.
30. Schiffman M, Wheeler CM, Dasgupta A, Solomon D, Castle PE. 2005. A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears. Am J Clin Pathol 124:722-732.
31. Schneider A, Hoyer H, Lotz B, Leistritz S, Kühne-Heid R, Nindl I, Müller B, Haerting J, Dürst M. 2000. Screening for high grade cervical intraepithelial neoplasia and cancer by testing for high risk HPV, routine cytology, or colposcopy. Int J Cancer 89:529-534.
32. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Munoz N, Snijders PJ, Meijer CJ, Franceschi S. 2004. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: A population-based study. Br J Cancer 90:638-645.
33. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
34. Xi LF, Carter JJ, Galloway DA, Kuypers J, Hughes JP, Lee S-K, Adam DE, Kiviat NB, Koutsky LA. 2002. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort study of female university students. Cancer Epidemiol Biomarkers Prev 11:343-351.
35. zur Hausen H. 2000. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690-698.